Pembrolizumab Imports from SOUTH KOREA to India — Trade Data & Analysis

Name: SOUTH KOREA to India Pembrolizumab Bilateral Import Data — 1 Suppliers, 1 Buyers, $10.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

TransData Nexus

Pembrolizumab

India Pharmaceutical Trade Intelligence

$1.9M34 Suppliers21 CountriesHS 30021500

ExportsIndia → BRAZIL44.6%India → ZIMBABWE8.5%

ImportsIRELAND → India$2.3B SINGAPORE → India$85.8M

#1 Supplier: GNH INDIA #1 Buyer: INDIRA GANDHI

Pembrolizumab Imports from SOUTH KOREA to India (2026) — $10.8M USD, 6 Shipments, Top Suppliers | TransData Nexus | TransData Nexus

Who Supplies Pembrolizumab to India from SOUTH KOREA

India's pembrolizumab imports from SOUTH KOREA total $10.8M across 6 shipments from 1 foreign suppliers. NUVISAN FRANCE SARL leads with $10.8M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for pembrolizumab — a concentrated sourcing relationship with select suppliers from SOUTH KOREA.

Source: Indian Customs (DGFT) Import Records · TransData NexusUpdated February 2026

Top foreign suppliers (SOUTH KOREA) — Ranked by import value

NUVISAN FRANCE SARL is the leading Pembrolizumab supplier from SOUTH KOREA to India, with import value of $10.8M across 6 shipments. The top 5 suppliers — NUVISAN FRANCE SARL — collectively account for 100.0% of total import value from this origin.

Top foreign suppliers (SOUTH KOREA)

Ranked by import value (USD) · Indian Customs (DGFT) data

Feb 2026

Top Pembrolizumab suppliers from SOUTH KOREA to India — ranked by import value (USD). 1 suppliers. Indian Customs (DGFT) data compiled by TransData Nexus.
#	Supplier	Value (USD)	Shipments	Share
1	NUVISAN FRANCE SARL	$10.8M	6	100.0%

Showing top 1 of 1 foreign suppliers · Indian Customs (DGFT) · TransData Nexus

Top Indian buyers (importing from SOUTH KOREA)

Ranked by import value (USD)

Top Indian buyers of Pembrolizumab from SOUTH KOREA — ranked by import value
#	Buyer	Value (USD)	Shipments	Share
1	FORTREA DEVELOPMENT INDIA PRIVATE LIMITED	$10.8M	6	100.0%

Frequently Asked Questions — Pembrolizumab Imports from SOUTH KOREA

Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus

QWho are the top Pembrolizumab suppliers from SOUTH KOREA to India?

The top Pembrolizumab suppliers from SOUTH KOREA to India include NUVISAN FRANCE SARL. The leading supplier is NUVISAN FRANCE SARL with import value of $10.8M USD across 6 shipments. India imported Pembrolizumab worth $10.8M USD from SOUTH KOREA in total across 6 shipments.

QHow much Pembrolizumab does India import from SOUTH KOREA?

India imported Pembrolizumab worth $10.8M USD from SOUTH KOREA across 6 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.

QWho are the main Indian buyers of Pembrolizumab from SOUTH KOREA?

The main Indian buyers of Pembrolizumab sourced from SOUTH KOREA include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. The largest buyer is FORTREA DEVELOPMENT INDIA PRIVATE LIMITED with $10.8M in imports across 6 shipments.

QWhat is the total value of Pembrolizumab imports from SOUTH KOREA to India?

The total value of Pembrolizumab imports from SOUTH KOREA to India is $10.8M USD, across 6 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).

Official References & Regulatory Resources

Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pembrolizumab

Pembrolizumab

Who Supplies Pembrolizumab to India from SOUTH KOREA

Top foreign suppliers (SOUTH KOREA) — Ranked by import value

Top foreign suppliers (SOUTH KOREA)

Top Indian buyers (importing from SOUTH KOREA)

Import Statistics

Other Pembrolizumab Import Origins

Related Analysis

Need Details?

Frequently Asked Questions — Pembrolizumab Imports from SOUTH KOREA

QWho are the top Pembrolizumab suppliers from SOUTH KOREA to India?

QHow much Pembrolizumab does India import from SOUTH KOREA?

QWho are the main Indian buyers of Pembrolizumab from SOUTH KOREA?

QWhat is the total value of Pembrolizumab imports from SOUTH KOREA to India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology